Skip to main content

Senator Josh Hawley Grills 23andMe CEO on Genetic Data Privacy

[HPP] Josh HawleyJanuary 24, 202612 min
29 connections·19 entities in this video→

Genetic Data Sale and Privacy Concerns

  • πŸ’‘ Senator Josh Hawley confronted the 23andMe CEO about the company's plan to sell genetic data from 14-15 million customers, including minors.
  • πŸ“Œ Hawley highlighted that 23andMe's own privacy commitment states information should not be shared without consumer consent, directly contradicting the planned sale.
  • ⚠️ The CEO's defense that consent is "not real" for research purposes was challenged, as Hawley argued the sale was not for research.

Consumer Control Over Data

  • 🧠 Hawley questioned the CEO's assertion that customers have "complete control" over their data, especially regarding deletion.
  • 🚨 It was revealed that 23andMe's deletion page went down after the sale announcement, making it difficult for customers to remove their data.
  • πŸ” Despite claims of full deletion, Hawley cited 23andMe's privacy policy, which states the company retains genetic information, date of birth, and sex even after an account is deleted.

Allegations of Deception and Accountability

  • βš–οΈ Senator Hawley accused 23andMe of lying to consumers about their data rights and profiting from this alleged deception.
  • πŸ›‘οΈ He raised national security implications due to the sensitive nature of genetic data being sold.
  • πŸ‘ Hawley emphasized the importance of strong oversight and suggested customers should consider suing the company for misleading them.
Knowledge graph19 entities Β· 29 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
19 entities
Chapters1 moments

Key Moments

Transcript48 segments

Full Transcript

Topics10 themes

What’s Discussed

Genetic dataData privacyConsumer consentPrivacy policyData deletionCorporate accountabilityNational security concernsMinors' genetic dataPharmaceutical industryCongressional oversight
Smart Objects19 Β· 29 links
CompanyΒ· 1
ConceptsΒ· 16
PeopleΒ· 2